Deadly gaps in the patent system : an analysis of current and alternative mechanisms for incentivising development of medical therapies.
The cost of medicines imposes a significant financial burden on society, with New Zealand spending $783.6 million between 2012 and 2013 alone. The majority of these costs are due to the monopoly prices charged for new patented drugs. The pharmaceutical industry argues that these high prices are nece...
| Main Author: | |
|---|---|
| Language: | en |
| Published: |
University of Canterbury. School of Law
2014
|
| Subjects: | |
| Online Access: | http://hdl.handle.net/10092/9826 |